Skip to main content
Erschienen in: European Radiology 7/2012

01.07.2012 | Urogenital

Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists

verfasst von: Ingfrid S. Haldorsen, Jenny A. Husby, Henrica M. J. Werner, Inger J. Magnussen, Jarle Rørvik, Harald Helland, Jone Trovik, Øyvind O. Salvesen, Ansgar Espeland, Helga B. Salvesen

Erschienen in: European Radiology | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate pelvic magnetic resonance imaging (MRI) interobserver agreement for the detection of deep myometrial invasion, cervical stroma invasion and lymph node metastases in endometrial carcinoma patients in relation to surgical staging.

Methods

Fifty-seven patients with histologically confirmed endometrial carcinoma were prospectively included in a study of preoperative 1.5-T MRI. Four radiologists, blinded to patient data, independently reviewed the images for the presence of deep myometrial invasion, cervical stroma invasion and lymph node metastases. Kappa coefficients for interobserver agreement and diagnostic performances for each observer were calculated using final surgical staging results (FIGO 09) as reference standard.

Results

Overall agreement among all observers was moderate for cervical stroma invasion (κ = 0.50 [95% CI 0.27–0.73]) and lymph node metastases (κ = 0.56 [0.09–0.80]) and fair for deep myometrial invasion (κ = 0.39 [0.26–0.55]). Sensitivity (specificity) values for the four observers were 72–92% (44–63%) for deep myometrial invasion, 38–63% (82–94%) for cervical stroma invasion and 25–38% (90–100%) for lymph node metastases.

Conclusions

Conventional MRI showed only modest interobserver agreement and diagnostic accuracy for detection of deep myometrial invasion, cervical stroma invasion and lymph node metastases. Improved methods are needed for preoperative imaging in the staging of endometrial carcinomas.

Key Points

MRI is an important tool for preoperative endometrial cancer staging.
Staging agreement based on pelvic MRI was modest among different observers.
Preoperative MRI alone was suboptimal in identifying high-risk patients.
Improved imaging and biomarkers may refine preoperative risk stratification in endometrial cancer.
Literatur
1.
Zurück zum Zitat Amant F, Moerman P, Neven P, Timmerman D, Van LE, Vergote I (2005) Endometrial cancer. Lancet 366:491–505PubMedCrossRef Amant F, Moerman P, Neven P, Timmerman D, Van LE, Vergote I (2005) Endometrial cancer. Lancet 366:491–505PubMedCrossRef
2.
Zurück zum Zitat Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S (2006) Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95:S105–S143PubMedCrossRef Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S (2006) Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95:S105–S143PubMedCrossRef
3.
Zurück zum Zitat Cohn DE, Woeste EM, Cacchio S, Zanagnolo VL, Havrilesky LJ, Mariani A, Podratz KC, Huh WK, Whitworth JM, McMeekin DS, Powell MA, Boyd E, Phillips GS, Fowler JM (2007) Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet Gynecol 109:1062–1067PubMedCrossRef Cohn DE, Woeste EM, Cacchio S, Zanagnolo VL, Havrilesky LJ, Mariani A, Podratz KC, Huh WK, Whitworth JM, McMeekin DS, Powell MA, Boyd E, Phillips GS, Fowler JM (2007) Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet Gynecol 109:1062–1067PubMedCrossRef
4.
Zurück zum Zitat Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375:1165–1172PubMedCrossRef Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375:1165–1172PubMedCrossRef
5.
Zurück zum Zitat Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125–136PubMedCrossRef Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125–136PubMedCrossRef
6.
Zurück zum Zitat Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, Hricak H (1999) Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212:711–718PubMed Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, Hricak H (1999) Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212:711–718PubMed
7.
Zurück zum Zitat Sala E, Wakely S, Senior E, Lomas D (2007) MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 188:1577–1587PubMedCrossRef Sala E, Wakely S, Senior E, Lomas D (2007) MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol 188:1577–1587PubMedCrossRef
8.
Zurück zum Zitat Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13:850–855PubMedCrossRef Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13:850–855PubMedCrossRef
9.
Zurück zum Zitat Koyama T, Tamai K, Togashi K (2007) Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol 17:2009–2019PubMedCrossRef Koyama T, Tamai K, Togashi K (2007) Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol 17:2009–2019PubMedCrossRef
10.
Zurück zum Zitat Cabrita S, Rodrigues H, Abreu R, Martins M, Teixeira L, Marques C, Mota F, de Oliveira CF (2008) Magnetic resonance imaging in the preoperative staging of endometrial carcinoma. Eur J Gynaecol Oncol 29:135–137PubMed Cabrita S, Rodrigues H, Abreu R, Martins M, Teixeira L, Marques C, Mota F, de Oliveira CF (2008) Magnetic resonance imaging in the preoperative staging of endometrial carcinoma. Eur J Gynaecol Oncol 29:135–137PubMed
11.
Zurück zum Zitat Rockall AG, Meroni R, Sohaib SA, Reynolds K, Alexander-Sefre F, Shepherd JH, Jacobs I, Reznek RH (2007) Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 17:188–196PubMedCrossRef Rockall AG, Meroni R, Sohaib SA, Reynolds K, Alexander-Sefre F, Shepherd JH, Jacobs I, Reznek RH (2007) Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 17:188–196PubMedCrossRef
12.
Zurück zum Zitat Sala E, Crawford R, Senior E, Shaw A, Simcock B, Vrotsou K, Palmer C, Rajan P, Joubert I, Lomas D (2009) Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 19:141–146PubMedCrossRef Sala E, Crawford R, Senior E, Shaw A, Simcock B, Vrotsou K, Palmer C, Rajan P, Joubert I, Lomas D (2009) Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 19:141–146PubMedCrossRef
13.
Zurück zum Zitat Undurraga M, Petignat P, Pelte MF, Jacob S, Dubuisson JB, Loubeyre P (2009) Magnetic resonance imaging to identify risk of lymph node metastasis in patients with endometrial cancer. Int J Gynaecol Obstet 104:233–235PubMedCrossRef Undurraga M, Petignat P, Pelte MF, Jacob S, Dubuisson JB, Loubeyre P (2009) Magnetic resonance imaging to identify risk of lymph node metastasis in patients with endometrial cancer. Int J Gynaecol Obstet 104:233–235PubMedCrossRef
14.
Zurück zum Zitat Haldorsen IS, Salvesen HB (2012) Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. Clin Radiol 67:2–12PubMedCrossRef Haldorsen IS, Salvesen HB (2012) Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. Clin Radiol 67:2–12PubMedCrossRef
15.
Zurück zum Zitat Kinkel K, Forstner R, Danza FM, Oleaga L, Cunha TM, Bergman A, Barentsz JO, Balleyguier C, Brkljacic B, Spencer JA (2009) Staging of endometrial cancer with MRI: Guidelines of the European Society of Urogenital Imaging. Eur Radiol 19:1565–1574PubMedCrossRef Kinkel K, Forstner R, Danza FM, Oleaga L, Cunha TM, Bergman A, Barentsz JO, Balleyguier C, Brkljacic B, Spencer JA (2009) Staging of endometrial cancer with MRI: Guidelines of the European Society of Urogenital Imaging. Eur Radiol 19:1565–1574PubMedCrossRef
16.
Zurück zum Zitat Hori M, Kim T, Murakami T, Imaoka I, Onishi H, Nakamoto A, Nakaya Y, Tomoda K, Tsutsui T, Enomoto T, Kimura T, Nakamura H (2009) MR imaging of endometrial carcinoma for preoperative staging at 3.0 T: comparison with imaging at 1.5 T. J Magn Reson Imaging 30:621–630PubMedCrossRef Hori M, Kim T, Murakami T, Imaoka I, Onishi H, Nakamoto A, Nakaya Y, Tomoda K, Tsutsui T, Enomoto T, Kimura T, Nakamura H (2009) MR imaging of endometrial carcinoma for preoperative staging at 3.0 T: comparison with imaging at 1.5 T. J Magn Reson Imaging 30:621–630PubMedCrossRef
17.
Zurück zum Zitat Lin G, Ng KK, Chang CJ, Wang JJ, Ho KC, Yen TC, Wu TI, Wang CC, Chen YR, Huang YT, Ng SH, Jung SM, Chang TC, Lai CH (2009) Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging – initial experience. Radiology 250:784–792PubMedCrossRef Lin G, Ng KK, Chang CJ, Wang JJ, Ho KC, Yen TC, Wu TI, Wang CC, Chen YR, Huang YT, Ng SH, Jung SM, Chang TC, Lai CH (2009) Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging – initial experience. Radiology 250:784–792PubMedCrossRef
18.
Zurück zum Zitat Rechichi G, Galimberti S, Signorelli M, Perego P, Valsecchi MG, Sironi S (2010) Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T. Eur Radiol 20:754–762PubMedCrossRef Rechichi G, Galimberti S, Signorelli M, Perego P, Valsecchi MG, Sironi S (2010) Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T. Eur Radiol 20:754–762PubMedCrossRef
19.
Zurück zum Zitat Scoutt LM, McCarthy SM, Flynn SD, Lange RC, Long F, Smith RC, Chambers SK, Kohorn E, Schwartz P, Chambers JT (1995) Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging. Work in progress. Radiology 194:567–572PubMed Scoutt LM, McCarthy SM, Flynn SD, Lange RC, Long F, Smith RC, Chambers SK, Kohorn E, Schwartz P, Chambers JT (1995) Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging. Work in progress. Radiology 194:567–572PubMed
20.
Zurück zum Zitat Seki H, Takano T, Sakai K (2000) Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix. AJR Am J Roentgenol 175:171–176PubMed Seki H, Takano T, Sakai K (2000) Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix. AJR Am J Roentgenol 175:171–176PubMed
21.
Zurück zum Zitat Torricelli P, Ferraresi S, Fiocchi F, Ligabue G, Jasonni VM, Di MI, Rivasi F (2008) 3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer. AJR Am J Roentgenol 190:489–495PubMedCrossRef Torricelli P, Ferraresi S, Fiocchi F, Ligabue G, Jasonni VM, Di MI, Rivasi F (2008) 3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer. AJR Am J Roentgenol 190:489–495PubMedCrossRef
22.
Zurück zum Zitat Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104PubMedCrossRef Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104PubMedCrossRef
23.
Zurück zum Zitat Silverberg SG, Kurman RJ, Nogales F et al (2003) Tumors of the uterine corpus: epithelial tumors and related lesions. In: Tavassoli FA, Devilee P (eds) WHO Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. IARC Press, Lyon, pp 221–232 Silverberg SG, Kurman RJ, Nogales F et al (2003) Tumors of the uterine corpus: epithelial tumors and related lesions. In: Tavassoli FA, Devilee P (eds) WHO Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. IARC Press, Lyon, pp 221–232
24.
Zurück zum Zitat Fleiss JL, Levin B, Paik MC (2004) The Measurement of Interrater Agreement. In: Statistical Methods for Rates and Proportions, 3 rdth edn. Wiley, New York Fleiss JL, Levin B, Paik MC (2004) The Measurement of Interrater Agreement. In: Statistical Methods for Rates and Proportions, 3 rdth edn. Wiley, New York
25.
Zurück zum Zitat Gordts S, Brosens JJ, Fusi L, Benagiano G, Brosens I (2008) Uterine adenomyosis: a need for uniform terminology and consensus classification. Reprod Biomed Online 17:244–248PubMedCrossRef Gordts S, Brosens JJ, Fusi L, Benagiano G, Brosens I (2008) Uterine adenomyosis: a need for uniform terminology and consensus classification. Reprod Biomed Online 17:244–248PubMedCrossRef
26.
Zurück zum Zitat Bankier AA, Levine D, Halpern EF, Kressel HY (2010) Consensus interpretation in imaging research: is there a better way? Radiology 257:14–17PubMedCrossRef Bankier AA, Levine D, Halpern EF, Kressel HY (2010) Consensus interpretation in imaging research: is there a better way? Radiology 257:14–17PubMedCrossRef
27.
Zurück zum Zitat Mower WR (1999) Evaluating bias and variability in diagnostic test reports. Ann Emerg Med 33:85–91PubMedCrossRef Mower WR (1999) Evaluating bias and variability in diagnostic test reports. Ann Emerg Med 33:85–91PubMedCrossRef
28.
Zurück zum Zitat Manfredi R, Gui B, Maresca G, Fanfani F, Bonomo L (2005) Endometrial cancer: magnetic resonance imaging. Abdom Imaging 30:626–636PubMedCrossRef Manfredi R, Gui B, Maresca G, Fanfani F, Bonomo L (2005) Endometrial cancer: magnetic resonance imaging. Abdom Imaging 30:626–636PubMedCrossRef
29.
Zurück zum Zitat Sala E, Rockall A, Kubik-Huch RA (2011) Advances in magnetic resonance imaging of endometrial cancer. Eur Radiol 21:468–473PubMedCrossRef Sala E, Rockall A, Kubik-Huch RA (2011) Advances in magnetic resonance imaging of endometrial cancer. Eur Radiol 21:468–473PubMedCrossRef
30.
Zurück zum Zitat Sanjuan A, Cobo T, Pahisa J, Escaramis G, Ordi J, Ayuso JR, Garcia S, Hernandez S, Torne A, Martinez RS, Lejarcegui JA, Vanrell JA (2006) Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section. Int J Gynecol Cancer 16:385–390PubMedCrossRef Sanjuan A, Cobo T, Pahisa J, Escaramis G, Ordi J, Ayuso JR, Garcia S, Hernandez S, Torne A, Martinez RS, Lejarcegui JA, Vanrell JA (2006) Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section. Int J Gynecol Cancer 16:385–390PubMedCrossRef
31.
Zurück zum Zitat Chung HH, Kang SB, Cho JY, Kim JW, Park NH, Song YS, Kim SH, Lee HP (2007) Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma. Gynecol Oncol 104:654–659PubMedCrossRef Chung HH, Kang SB, Cho JY, Kim JW, Park NH, Song YS, Kim SH, Lee HP (2007) Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma. Gynecol Oncol 104:654–659PubMedCrossRef
32.
Zurück zum Zitat Akaeda T, Isaka K, Takayama M, Kakizaki D, Abe K (2005) Myometrial invasion and cervical invasion by endometrial carcinoma: evaluation by CO2-volumetric interpolated breathhold examination (VIBE). J Magn Reson Imaging 21:166–171PubMedCrossRef Akaeda T, Isaka K, Takayama M, Kakizaki D, Abe K (2005) Myometrial invasion and cervical invasion by endometrial carcinoma: evaluation by CO2-volumetric interpolated breathhold examination (VIBE). J Magn Reson Imaging 21:166–171PubMedCrossRef
33.
Zurück zum Zitat Nakao Y, Yokoyama M, Hara K, Koyamatsu Y, Yasunaga M, Araki Y, Watanabe Y, Iwasaka T (2006) MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol Oncol 102:343–347PubMedCrossRef Nakao Y, Yokoyama M, Hara K, Koyamatsu Y, Yasunaga M, Araki Y, Watanabe Y, Iwasaka T (2006) MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol Oncol 102:343–347PubMedCrossRef
34.
Zurück zum Zitat Ortashi O, Jain S, Emannuel O, Henry R, Wood A, Evans J (2008) Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer. A prospective study of 100 cases at the Dorset Cancer Centre. Eur J Obstet Gynecol Reprod Biol 137:232–235PubMedCrossRef Ortashi O, Jain S, Emannuel O, Henry R, Wood A, Evans J (2008) Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer. A prospective study of 100 cases at the Dorset Cancer Centre. Eur J Obstet Gynecol Reprod Biol 137:232–235PubMedCrossRef
35.
Zurück zum Zitat Vasconcelos C, Felix A, Cunha TM (2007) Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation. J Obstet Gynaecol 27:65–70PubMedCrossRef Vasconcelos C, Felix A, Cunha TM (2007) Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation. J Obstet Gynaecol 27:65–70PubMedCrossRef
36.
Zurück zum Zitat Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF, Giordano D, Scambia G, Marano P (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231:372–378PubMedCrossRef Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF, Giordano D, Scambia G, Marano P (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231:372–378PubMedCrossRef
37.
Zurück zum Zitat Sanjuan A, Escaramis G, Ayuso JR, Roman SM, Torne A, Ordi J, Lejarcegui JA, Pahisa J (2008) Role of magnetic resonance imaging and cause of pitfalls in detecting myometrial invasion and cervical involvement in endometrial cancer. Arch Gynecol Obstet 278:535–539PubMedCrossRef Sanjuan A, Escaramis G, Ayuso JR, Roman SM, Torne A, Ordi J, Lejarcegui JA, Pahisa J (2008) Role of magnetic resonance imaging and cause of pitfalls in detecting myometrial invasion and cervical involvement in endometrial cancer. Arch Gynecol Obstet 278:535–539PubMedCrossRef
38.
Zurück zum Zitat Sironi S, Colombo E, Villa G, Taccagni G, Belloni C, Garancini P, DelMaschio A (1992) Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 185:207–212PubMed Sironi S, Colombo E, Villa G, Taccagni G, Belloni C, Garancini P, DelMaschio A (1992) Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 185:207–212PubMed
39.
Zurück zum Zitat Loubeyre P, Undurraga M, Bodmer A, Petignat P (2011) Non-invasive modalities for predicting lymph node spread in early stage endometrial cancer? Surg Oncol 20:e102–e108PubMedCrossRef Loubeyre P, Undurraga M, Bodmer A, Petignat P (2011) Non-invasive modalities for predicting lymph node spread in early stage endometrial cancer? Surg Oncol 20:e102–e108PubMedCrossRef
40.
Zurück zum Zitat Narayanan P, Iyngkaran T, Sohaib SA, Reznek RH, Rockall AG (2009) Pearls and pitfalls of MR lymphography in gynecologic malignancy. Radiographics 29:1057–1069PubMedCrossRef Narayanan P, Iyngkaran T, Sohaib SA, Reznek RH, Rockall AG (2009) Pearls and pitfalls of MR lymphography in gynecologic malignancy. Radiographics 29:1057–1069PubMedCrossRef
41.
Zurück zum Zitat Shen SH, Chiou YY, Wang JH, Yen MS, Lee RC, Lai CR, Chang CY (2008) Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 190:481–488PubMedCrossRef Shen SH, Chiou YY, Wang JH, Yen MS, Lee RC, Lai CR, Chang CY (2008) Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 190:481–488PubMedCrossRef
42.
Zurück zum Zitat Takeuchi M, Matsuzaki K, Nishitani H (2009) Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion. Acta Radiol 50:947–953PubMedCrossRef Takeuchi M, Matsuzaki K, Nishitani H (2009) Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion. Acta Radiol 50:947–953PubMedCrossRef
43.
Zurück zum Zitat Joja I, Asakawa M, Asakawa T, Nakagawa T, Kanazawa S, Kuroda M, Togami I, Hiraki Y, Akamatsu N, Kudo T (1996) Endometrial carcinoma: dynamic MRI with turbo-FLASH technique. J Comput Assist Tomogr 20:878–887PubMedCrossRef Joja I, Asakawa M, Asakawa T, Nakagawa T, Kanazawa S, Kuroda M, Togami I, Hiraki Y, Akamatsu N, Kudo T (1996) Endometrial carcinoma: dynamic MRI with turbo-FLASH technique. J Comput Assist Tomogr 20:878–887PubMedCrossRef
44.
Zurück zum Zitat Trovik J, Wik E, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC, Njolstad TS, Vandenput I, Amant F, Akslen LA, Salvesen HB (2011) Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer. Clin Cancer Res 17:3368–3377PubMedCrossRef Trovik J, Wik E, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC, Njolstad TS, Vandenput I, Amant F, Akslen LA, Salvesen HB (2011) Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer. Clin Cancer Res 17:3368–3377PubMedCrossRef
45.
Zurück zum Zitat Engelsen IB, Stefansson I, Akslen LA, Salvesen HB (2006) Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas. Am J Obstet Gynecol 195:979–986PubMedCrossRef Engelsen IB, Stefansson I, Akslen LA, Salvesen HB (2006) Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas. Am J Obstet Gynecol 195:979–986PubMedCrossRef
46.
Zurück zum Zitat Engelsen IB, Stefansson IM, Akslen LA, Salvesen HB (2008) GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival. Am J Obstet Gynecol 199:543–547PubMedCrossRef Engelsen IB, Stefansson IM, Akslen LA, Salvesen HB (2008) GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival. Am J Obstet Gynecol 199:543–547PubMedCrossRef
Metadaten
Titel
Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists
verfasst von
Ingfrid S. Haldorsen
Jenny A. Husby
Henrica M. J. Werner
Inger J. Magnussen
Jarle Rørvik
Harald Helland
Jone Trovik
Øyvind O. Salvesen
Ansgar Espeland
Helga B. Salvesen
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 7/2012
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2400-y

Weitere Artikel der Ausgabe 7/2012

European Radiology 7/2012 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.